Acute myeloid leukemia (AML)
A rapidly progressing myeloid cancer with several genetic and molecular subtypes.
Blood cancer diagnosis and treatment
Leukemia Treatment in Turkey
Information about leukemia treatment in Turkey, including AML, ALL, CML, and CLL, diagnostic tests, molecular classification, modern therapies, medical records, and cost factors.
Precise disease classificationLeukemia treatment begins with confirming the exact subtype.
Molecularly guided decisionsGenetic findings can affect prognosis and selected therapies.
Specialized hematology careTreatment often requires coordinated inpatient and outpatient support.
What to know
Leukemia is not one disease and treatment varies greatly by subtype
Leukemia begins in blood-forming tissues and leads to abnormal blood cells. Acute leukemias can progress quickly and often require urgent treatment, while some chronic leukemias develop more slowly and may initially be monitored.
The diagnosis is usually based on blood and bone marrow testing. Flow cytometry, chromosome analysis, FISH, and molecular tests help classify the leukemia, identify treatment targets, and estimate risk.
Conditions and clinical areas
Main leukemia groups evaluated by hematology teams
Each leukemia subtype has different biology, urgency, treatment phases, and follow-up requirements.
Acute lymphoblastic leukemia (ALL)
An acute lymphoid leukemia requiring multi-phase treatment and central nervous system prevention.
Chronic myeloid leukemia (CML)
Usually associated with the BCR::ABL1 fusion and commonly treated with targeted medicines.
Chronic lymphocytic leukemia (CLL)
A lymphoid leukemia that may be monitored when asymptomatic or treated when progressive.
Acute promyelocytic leukemia (APL)
A distinct AML subtype that requires urgent recognition and specialized treatment.
Relapsed or refractory leukemia
Disease that returns or does not respond may require alternative medicines, immunotherapy, clinical trials, or transplant assessment.
Diagnosis and evaluation
Tests used to confirm and classify leukemia
The work-up establishes the cell lineage, subtype, genetic profile, disease burden, and organ status before treatment.
Blood count and peripheral smear
Abnormal white cells, anemia, and platelet changes can suggest leukemia but do not define the subtype.
Bone marrow aspiration and biopsy
Marrow testing confirms disease and provides material for morphology, flow cytometry, and genetic analysis.
Cytogenetic and molecular testing
Chromosome changes and gene mutations can influence risk classification, targeted treatment, and transplant decisions.
Possible treatment approaches
Leukemia treatment is adapted to the subtype and risk group
Treatment may be given in phases and can include systemic therapy, targeted medicines, immune-based treatment, and stem cell transplantation.
Chemotherapy
Combination regimens are central to many acute leukemias and selected chronic leukemias.
Targeted therapy
Medicines may target BCR::ABL1 or other specific molecular abnormalities.
Immunotherapy
Antibodies, bispecific therapies, or other immune-based approaches may be used for selected patients.
CAR T-cell therapy
For selected relapsed or refractory leukemias, genetically modified T cells may be considered at specialized centers.
Supportive treatment
Transfusions, infection prevention, antibiotics, and management of treatment complications are essential.
Stem cell transplantation
Allogeneic transplant may be considered according to subtype, risk, response, donor availability, and patient fitness.
Medical records
Records needed for a leukemia second opinion
The most useful documents show the exact subtype, genetic profile, treatment response, and current disease status.
Clinical and treatment summaryDate of diagnosis, symptoms, treatment phases, complications, response, and current medicines.
Blood-count resultsCurrent and previous complete blood counts, differential counts, and smear findings.
Bone marrow reportsMorphology, biopsy, blast percentage, flow cytometry, and measurable residual disease results.
Genetic and molecular resultsKaryotype, FISH, mutation panels, BCR::ABL1, and other subtype-specific tests.
Imaging and organ assessmentsImaging or cardiac, liver, kidney, and infection evaluations performed before treatment.
Current clinical questionDiagnosis confirmation, treatment choice, relapse management, transplant, or cost estimation.
Specialist departments
Teams involved in leukemia care
Acute leukemia treatment may require continuous coordination across hematology, laboratory medicine, infectious diseases, transfusion services, and transplant care.
Leukemia hematology
Directs diagnosis, treatment phases, response assessment, and long-term follow-up.
Hematopathology and flow cytometry
Defines cell lineage and subtype and monitors residual disease.
Cytogenetics and molecular laboratory
Identifies risk markers, treatment targets, and molecular response.
Infectious diseases
Manages prevention and treatment of infections during immune suppression.
Transfusion medicine
Supports anemia, thrombocytopenia, cell collection, and blood-product needs.
Stem cell transplant team
Evaluates transplant indication, donor options, timing, and post-transplant care.
Treatment cost in Turkey
Leukemia treatment cost depends on subtype and treatment intensity
Costs vary substantially between monitoring of a stable chronic leukemia and intensive inpatient treatment for acute leukemia. Molecular tests, medicines, hospital stay, transfusions, and transplant assessment all influence the estimate. More general information is available on the treatment pricing page.
- Acute or chronic leukemia subtype and risk group
- Bone marrow, flow cytometry, genetics, and molecular monitoring
- Inpatient treatment and number of chemotherapy cycles
- Targeted, immune, or cellular therapies
- Stem cell transplant evaluation and donor testing
Frequently asked questions
Answers before sending medical records
Can leukemia be diagnosed from a blood test alone?
Blood tests may strongly suggest leukemia, but bone marrow, flow cytometry, and genetic tests are commonly needed to confirm and classify it.
Is every leukemia treated immediately?
Acute leukemias generally require urgent specialist care. Some chronic leukemias without symptoms may be monitored until treatment criteria are met.
Why are genetic tests important?
They help define the subtype, estimate risk, identify treatment targets, and measure response in some leukemias.
Can a leukemia second opinion be requested remotely?
Often yes. The physician usually needs the marrow report, flow cytometry, cytogenetics, molecular tests, treatment summary, and latest blood counts.
When is stem cell transplant considered?
It may be considered for selected high-risk, relapsed, or refractory disease based on response, age, health, donor availability, and other factors.
Is CAR T-cell therapy used for leukemia?
It may be an option for selected patients with certain relapsed or refractory lymphoid leukemias at specialized centers.
Can treatment cost be estimated before travel?
A preliminary estimate can be prepared after detailed review, but the final cost depends on response, complications, and changes in the treatment plan.
What symptoms require urgent local care?
Fever, bleeding, breathing difficulty, confusion, severe weakness, or rapidly worsening blood counts require urgent local medical assessment.
Contact Medicina Turkey
Do you need information about leukemia treatment in Turkey?
Send the leukemia subtype, treatment history, current blood counts, bone marrow, flow cytometry, genetic and molecular results, and your main clinical question.
Medical sources:
- National Cancer Institute — Leukemia
- National Cancer Institute — AML Treatment
- National Cancer Institute — ALL Treatment
- National Cancer Institute — Leukemia Research
This page provides general educational information and does not replace a medical examination, diagnosis, or individualized treatment plan. Treatment options and outcomes vary according to the clinical situation.